| Kyle D Craig, MD | |
|
3400 Frank Phillips, Ste 602, Bartlesville, OK 74006 | |
| (918) 338-3790 | |
| (918) 338-3789 |
| Full Name | Kyle D Craig |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 3400 Frank Phillips, Bartlesville, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528138633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A85663 (California) | Secondary |
| 207Q00000X | Family Medicine | 25600 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Bartlesville, OK | Home health agency |
| Jane Phillips Regional Home Care, Llc | Bartlesville, OK | Home health agency |
| Jane Phillips Memorial Medical Center, Inc | Bartlesville, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St John Physicians Inc | 2567366495 | 223 |
News Archive
A Melbourne-based research team has discovered a genetic defect that can halt cell growth and force cells into a death-evading survival state.
A particular gene variant might make women more susceptible to alcoholism. At least, a study carried out by the Universities of Bonn and Sweden's Karolinska Institute makes this a plausible conclusion.
The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).
Gen-Probe Incorporated announced today that it is spinning off its industrial testing assets into a new, independent company focused on developing rapid, highly accurate molecular assays for biopharmaceutical production, water and food safety testing, and other applications.
While several clinical trials have demonstrated that maintenance therapy with lenalidomide reduces the risk of disease progression in patients with multiple myeloma, there have been no definitive results regarding overall survival.
› Verified 5 days ago
| Entity Name | St John Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336194406 PECOS PAC ID: 2567366495 Enrollment ID: O20031121000867 |
News Archive
A Melbourne-based research team has discovered a genetic defect that can halt cell growth and force cells into a death-evading survival state.
A particular gene variant might make women more susceptible to alcoholism. At least, a study carried out by the Universities of Bonn and Sweden's Karolinska Institute makes this a plausible conclusion.
The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).
Gen-Probe Incorporated announced today that it is spinning off its industrial testing assets into a new, independent company focused on developing rapid, highly accurate molecular assays for biopharmaceutical production, water and food safety testing, and other applications.
While several clinical trials have demonstrated that maintenance therapy with lenalidomide reduces the risk of disease progression in patients with multiple myeloma, there have been no definitive results regarding overall survival.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle D Craig, MD 226 Se Debell, Bldg A, Bartlesville, OK 74006 Ph: (918) 331-1090 | Kyle D Craig, MD 3400 Frank Phillips, Ste 602, Bartlesville, OK 74006 Ph: (918) 338-3790 |
News Archive
A Melbourne-based research team has discovered a genetic defect that can halt cell growth and force cells into a death-evading survival state.
A particular gene variant might make women more susceptible to alcoholism. At least, a study carried out by the Universities of Bonn and Sweden's Karolinska Institute makes this a plausible conclusion.
The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).
Gen-Probe Incorporated announced today that it is spinning off its industrial testing assets into a new, independent company focused on developing rapid, highly accurate molecular assays for biopharmaceutical production, water and food safety testing, and other applications.
While several clinical trials have demonstrated that maintenance therapy with lenalidomide reduces the risk of disease progression in patients with multiple myeloma, there have been no definitive results regarding overall survival.
› Verified 5 days ago
Elizabeth R Sherrock, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4150 Se Adams Rd, Bartlesville, OK 74104 Phone: 918-331-9979 Fax: 918-331-2346 | |
Kimberly Nichole Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 E Frank Phillips Blvd Ste 300, Bartlesville, OK 74006 Phone: 918-331-2415 | |
Blythe H Zielenski, P.A. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Frank Phillips, Suite 702, Bartlesville, OK 74006 Phone: 918-331-2500 Fax: 918-331-2506 | |
William W Davito, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4150 Se Adams Rd, Bartlesville, OK 74104 Phone: 918-331-9979 Fax: 918-331-2346 | |
Sheri L Reinhard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3400 E Frank Phillips Blvd, Suite 702, Bartlesville, OK 74006 Phone: 918-331-2500 Fax: 918-331-2506 | |
Scarlett Florence Custer, D. O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2431 Nowata Pl, Bartlesville, OK 74006 Phone: 918-333-5521 Fax: 918-333-7139 | |
Gerald F Pribil, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3450 E Frank Phillips Blvd Ste 300, Bartlesville, OK 74006 Phone: 918-331-3760 Fax: 918-331-3761 |